Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: Response to Mark [12]

Diabetes Care

Volumn 29, Issue 12, 2006, Pages 2764-2765

  Martin, Julie ^a   Matthews, Dwight ^a   Cefalu, William T ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; PLACEBO; CHROMIUM; INSULIN;

ADIPOSE TISSUE; BODY FAT; BODY WEIGHT; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG POTENTIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; GASTROINTESTINAL SYMPTOM; HUMAN; INSULIN SENSITIVITY; LETTER; MUSCLE MASS; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT GAIN; WEIGHT REDUCTION; DRUG COMBINATION; DRUG EFFECT; NOTE; OBESITY; PATHOPHYSIOLOGY;

CHROMIUM; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; HUMANS; INSULIN; OBESITY; WEIGHT GAIN;

EID: 33845501206     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1852     Document Type: Letter

References (7)

1. Mark DA: Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes (Letter). Diabetes Care 29:2764, 2006
2. Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, Cefalu WT: Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29:1826-1832, 2006
3. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chenc N, Chi J, Feng J: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:1786-1791, 1997
4. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, Terry JG: Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12:71-83, 1999
5. Guntun JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A: Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28:712-713, 2005
6. Kleefstra N, Houweling ST, Jansman FGA, Groenier KH, Gans ROB, Meyboom-de Jong B, Bakker SJL, Bilo HJG: Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 29:521-525, 2006
7. Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65:385-411, 2005